Concepedia

Author

Ayaka Edo

RIKEN Center for Biosystems Dynamics ResearchORCID

Also Known As

A Edo, A VILLANUEVA EDO, A. Edo, Andreu Edo, Ayaka Edo

27

Publications

202

Citations

9

H-Index

29

Concepts

All Affiliations

RIKEN Center for Biosystems Dynamics ResearchVall d'Hebron Hospital UniversitariHospital Universitario Puerta de Hierro MajadahondaResearch Institute Hospital 12 de OctubreHiroshima University
AE

About

Ayaka Edo is an author at RIKEN Center for Biosystems Dynamics Research specializing in medicine, immunology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

41

2

Hepatology

2

2

23

3

Health Sciences

1

1

18

4

Cell Biology

1

1

18

5

Cellular Therapies

1

1

18

Ayaka Edo

×

9

Publications

166

Citations

9

H-Index

YearCitations

A Strategy for Personalized Treatment of iPS-Retinal Immune Rejections Assessed in Cynomolgus Monkey Models

Shota Fujii, Sunao Sugita, Masaaki Ishida,

International Journal of Molecular Sciences

2020

26

Recipient hepatectomy with preservation of inferior vena cava reduces the need for veno-venous bypass in liver transplantation

Carlos Margarit, J. Lázaro, J. Balsells,

Transplant International

1994

25

Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation

Carlos Margarit, Antoni Rimola, I González-Pinto,

Transplant International

1998

24

Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem (iPS) Cells Suppress or Activate T Cells via Costimulatory Signals

Sunao Sugita, Masaaki Ishida, Ayaka Edo,

International Journal of Molecular Sciences

2020

21

Capacity of Retinal Ganglion Cells Derived from Human Induced Pluripotent Stem Cells to Suppress T-Cells

Ayaka Edo, Sunao Sugita, Junki Sho,

International Journal of Molecular Sciences

2020

18

Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation

Carlos Margarit, Antoni Rimola, I González-Pinto,

Transplant International

1998

16

Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?

R. Charco, Vı́ctor Vargas, Helena Allende,

Transplant International

1996

13

Liver transplantation in patients over 60 years of age.

Itxarone Bilbao, J. Balsells, J. L. Lázaro,

PubMed

1995

12

Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?

R. Charco, Vı́ctor Vargas, Helena Allende,

Transplant International

1996

11

Page 1